Atlantic Union Bankshares’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.8K Sell
115
-2
-2% -$383 ﹤0.01% 1114
2026
Q1
$21.4K Buy
117
+2
+2% +$369 ﹤0.01% 1113
2025
Q4
$20.2K Hold
115
﹤0.01% 1124
2025
Q3
$16.1K Hold
115
﹤0.01% 1179
2025
Q2
$14.4K Buy
+115
New +$14.3K ﹤0.01% 868
2019
Q4
Sell
-2,892
Closed -$673K 244
2019
Q3
$673K Sell
2,892
-425
-13% -$99K 0.09% 157
2019
Q2
$776K Buy
+3,317
New +$766K 0.1% 154

Other funds holding BIIB

Atlantic Union Bankshares's BIIB Position: Q2 2026 in Review

Atlantic Union Bankshares reduced its Biogen (BIIB) stake by 1.7% in Q2 2026, selling an estimated $383 and leaving 115 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1114.

Atlantic Union Bankshares first reported a position in BIIB in Q2 2019 and has held it in 7 quarters since. The position peaked at $776K in Q2 2019. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Atlantic Union Bankshares held 115 shares of Biogen worth $24.8K as of Q2 2026.
  • Atlantic Union Bankshares sold 2 Biogen shares in Q2 2026, an estimated $383.
  • Biogen made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #1114 holding.
  • Atlantic Union Bankshares first reported a position in Biogen in Q2 2019 and has held it in 7 quarters since.
  • Atlantic Union Bankshares's Biogen position peaked at $776K in Q2 2019.
  • 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.